Skip to main content
Year archive

MESOBLAST LTD — 2018 filings

All 107 regulatory filings released by MESOBLAST LTD (MESO) in 2018, sourced directly from the official regulator.

107 Filings
2018 Period
2018 filings (107)
Filing Released Lang
Mesoblast Corporate Review 3 pages 143.5KB
Management Reports
2018-12-27 English
Mesoblast to Present at 2019 Biotech Showcase in USA 1
Investor Presentation
2018-12-23 English
6-K
Regulatory Filings
2018-12-19 English
MSB Makes Executive Appointment To Drive Commercialization 2 pages 109.1KB
Board/Management Information
2018-12-18 English
Meetings Held With FDA Support MSB's Planned GVHD Filing 2 pages 96.0KB
Regulatory Filings
2018-12-12 English
6-K
Regulatory Filings
2018-12-05 English
Response to ASX query 3 pages 435.6KB
Regulatory Filings
2018-12-04 English
Chairman's Address to Shareholders 2 pages 81.1KB
AGM Information
2018-11-29 English
Presentation to 2018 Annual General Meeting 27 pages 1.4MB
AGM Information
2018-11-29 English
Results of Meeting 3 pages 177.8KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-29 English
6-K
Regulatory Filings
2018-11-27 English
Tasly and MSB Initiate Activities For MPC-150-IM In China 2 pages 349.0KB
Capital/Financing Update
2018-11-25 English
6-K
Investor Presentation
2018-11-21 English
Q1.FY19-30SEP2018
Interim / Quarterly Report
2018-11-16 English
6-K
Regulatory Filings
2018-11-16 English
First Quarter Financial Results on Form 6-K 90 pages 491.9KB
Interim / Quarterly Report Q1 2019
2018-11-15 English
First Quarter Results Presentation 39 pages 2.9MB
Interim / Quarterly Report Q1 2019
2018-11-15 English
MSB Provides Q1 Financial Results and Operational Highlights 7 pages 312.8KB
Interim / Quarterly Report Q1 2019
2018-11-15 English
LVAD Results Webcast Presentation 27 pages 1.7MB
Investor Presentation
2018-11-12 English
Pause in Trading 1 page 111.0KB
Regulatory Filings
2018-11-11 English
LVAD Trial Results Provide Potential Regulatory Pathway 4 pages 158.7KB
Capital/Financing Update
2018-11-11 English
MSB To Host Webcast For Heart Failure Results At AHA 1
Call Transcript
2018-11-08 English
6-K
Regulatory Filings
2018-11-07 English
6-K
Regulatory Filings
2018-10-31 English
Appendix 4C - quarterly 6 pages 129.5KB
Interim / Quarterly Report Q1 2019
2018-10-30 English
Appendix 4G and Corporate Governance Statement 19 pages 183.3KB
Governance Information
2018-10-29 English
Notice of General Meeting/Proxy Form 22 pages 317.2KB
AGM Information
2018-10-29 English
Annual Report to shareholders 230 pages 2.5MB
Annual Report FY 2018
2018-10-29 English
GVHD and CHF Updates to Emerging Leaders Conference 33 pages 2.6MB
Investor Presentation
2018-10-24 English
MSB Expands Partnership With JCR For Skin Disease 2 pages 98.6KB
Regulatory Filings
2018-10-23 English
6-K
Capital/Financing Update
2018-10-17 English
Change in substantial holding 5 pages 264.6KB
Major Shareholding Notification
2018-10-15 English
Completion of Tasly Transaction, and Appendix 3B 15 pages 245.6KB
Capital/Financing Update
2018-10-11 English
Release of shares from voluntary escrow 1 page 89.8
Regulatory Filings
2018-10-10 English
Regulatory Filings 2018
Regulatory Filings
2018-10-04 English
6-K
Regulatory Filings
2018-10-04 English
End-Stage HF Results Selected For AHA Scientific Sessions 2 pages 92.4KB
Regulatory Filings
2018-10-01 English
6-K
Regulatory Filings
2018-09-27 English
Mesoblast Cardiac Cell Therapy In Children 2 pages 98.5KB
Regulatory Filings
2018-09-24 English
6-K
Regulatory Filings
2018-09-21 English
Day 180 Survival Outcomes In aGvHD Phase 3 Trial 2 pages 106.3KB
Regulatory Filings
2018-09-19 English
Tasly Receives Approvals For Transaction With MSB 1
Capital/Financing Update
2018-09-16 English
6-K
Regulatory Filings
2018-08-31 English
20-F
Annual Report FY 2018
2018-08-31 English
Preliminary Final Report including Appendix 4E 231 pages 1.7MB
Annual Report FY 2018
2018-08-29 English
Annual Financial Results Presentation 30 pages 2.3MB
Annual Report FY 2018
2018-08-29 English
Mesoblast Reports on Annual and Fourth Quarter Results 8 pages 226.1KB
Annual Report FY 2018
2018-08-29 English
UPDATE ON TASLY TRANSACTION 2 pages 94.3KB
Capital/Financing Update
2018-08-28 English
6-K
Regulatory Filings
2018-08-02 English
Appendix 4C - quarterly 6 pages 120.3KB
Interim / Quarterly Report Q4 2018
2018-07-30 English
6-K
Director's Dealing
2018-07-24 English
6-K
Regulatory Filings
2018-07-19 English
Initial Director's Interest Notice 2 pages 68.3KB
Director's Dealing
2018-07-17 English
MSB Enters Into Cardiovascular Alliance For China With Tasly 2 pages 86.7KB
Capital/Financing Update
2018-07-16 English
6-K
Regulatory Filings
2018-07-13 English
Director Appointment/Resignation 2 pages 94.1KB
Board/Management Information
2018-07-10 English
Appendix 3B 12 pages 191.0KB
Capital/Financing Update
2018-07-09 English
6-K
Director's Dealing
2018-07-04 English
MSB Enters Into US$50M Financing With NovaQuest Capital 3 pages 86.4KB
Capital/Financing Update
2018-07-01 English
6-K
Investor Presentation
2018-06-28 English
Initial and Final Directors' Interest Notices 4 pages 84.1KB
Director's Dealing
2018-06-24 English
6-K
Regulatory Filings
2018-06-22 English
ISSCR Presentation on P3 GVHD Trial Survival Benefits 31 pages 1.9MB
Investor Presentation
2018-06-21 English
Key Day 100 Survival Results In P3 GvHD Trial 2 pages 81.7KB
Regulatory Filings
2018-06-20 English
6-K
Regulatory Filings
2018-06-20 English
Director Appointment/Resignation 2 pages 78.9KB
Board/Management Information
2018-06-18 English
6-K
Regulatory Filings
2018-06-01 English
6-K
Interim / Quarterly Report
2018-06-01 English
Third Quarter Financial Results on Form 6-K 89 pages 540.4KB
Interim / Quarterly Report 9M 2018
2018-05-30 English
Third Quarter Results Presentation 17 pages 991.8KB
Interim / Quarterly Report 9M 2018
2018-05-30 English
Mesoblast Appoints New Chief Financial Officer 2 pages 79.1KB
Board/Management Information
2018-05-30 English
MSB Provides Q3 Financial Results and Operational Highlights 7 pages 218.2KB
Interim / Quarterly Report 9M 2018
2018-05-30 English
6-K
Regulatory Filings
2018-05-30 English
Partnership For Allogeneic Cell-based Cancer Immunotherapies 2 pages 79.2KB
Regulatory Filings
2018-05-28 English
6-K
Capital/Financing Update
2018-05-18 English
Cleansing notice and Appendix 3B 7 pages 133.9KB
Capital/Financing Update
2018-05-14 English
6-K
Regulatory Filings
2018-05-10 English
MSB P3 Results For GVHD Presented At ISCT Meeting 2 pages 100.5KB
Investor Presentation
2018-05-07 English
6-K
Regulatory Filings
2018-05-04 English
MSB Cell Therapies Featured At Vatican Healthcare Conference 2 pages 77.5KB
Regulatory Filings
2018-04-30 English
Appendix 4C - quarterly 6 pages 118.9KB
Interim / Quarterly Report Q3 2018
2018-04-29 English
6-K
Regulatory Filings
2018-04-20 English
MSB Clinical Program Update For MPC-150-IM In Heart Failure 3 pages 114.4KB
Regulatory Filings
2018-04-17 English
6-K
Regulatory Filings
2018-03-30 English
Mesoblast Phase 3 CLBP Trial Completes Enrollment 3 pages 106.0KB
Regulatory Filings
2018-03-28 English
Change in substantial holding 6 pages 193.5KB
Regulatory Filings
2018-03-08 English
6-K
Regulatory Filings
2018-03-08 English
MSB Enters Into $75 Million Non-Dilutive Credit Facility 2 pages 98.9KB
Capital/Financing Update
2018-03-06 English
6-K
Interim / Quarterly Report
2018-02-28 English
6-K
Regulatory Filings
2018-02-28 English
Half Year Report and Accounts (including Appendix 4D) 92 pages 572.3KB
Interim / Quarterly Report H1 2018
2018-02-27 English
Half Year Results Presentation 41 pages 3.4MB
Investor Presentation
2018-02-27 English
Mesoblast Provides Half Year Results and Corporate Update 11 pages 242.4KB
Interim / Quarterly Report H1 2018
2018-02-27 English
6-K
Investor Presentation
2018-02-27 English
6-K
Regulatory Filings
2018-02-23 English
GVHD Day 28 Results Presentation 27 pages 1.9MB
Investor Presentation
2018-02-22 English
Primary Endpoint Successfully Achieved in MSB P3 GVHD Trial 3 pages 111.9KB
Regulatory Filings
2018-02-21 English
SC 13G/A
Major Shareholding Notification
2018-02-14 English
MESOBLAST LIMITED
Major Shareholding Notification
2018-02-14 English
SC 13G/A
Major Shareholding Notification
2018-02-14 English
6-K
Regulatory Filings
2018-02-07 English
Appendix 4C - quarterly 6 pages 100.5KB
Interim / Quarterly Report Q2 2018
2018-01-30 English
6-K
Capital/Financing Update
2018-01-25 English
Appendix 3B with prospectus 73 pages 492.2KB
Share Issue/Capital Change
2018-01-18 English
6-K
Investor Presentation
2018-01-18 English
Presentation to J.P. Morgan 2018 Healthcare Conference 43 pages 3.8MB
Investor Presentation
2018-01-11 English
Presentation at JP Morgan Healthcare Conference 2 pages 74.4KB
Investor Presentation
2018-01-10 English